Summary
Aswini Homeo Arnica Hair Oil remained a medicament under Chapter 30 of the Central Excise Tariff rather than a cosmetic under Chapter 33. Its composition and common understanding satisfied the twin tests; hair oil was the medium for applying its pharmaceutical ingredients. The 2012 tariff restructuring did not justify changing its settled classification. The Revenue’s appeal was dismissed without costs.
Issues
- Whether the homeopathic preparation was a medicament or cosmetic hair oil.
- Whether tariff restructuring justified reopening the product’s previously accepted classification.
Provisions considered
- First Schedule, Chapters 30 and 33; headings 3003, 3004 and 3305, Central Excise Tariff Act, 1985Applied the ingredients and common-parlance tests to retain medicament classification; retail packaging could be accommodated under subheading 3004 90 14. (¶¶ 6.1-6.2.2, 18, 21-34)
Held
- Classification required consideration together of common or commercial understanding and whether the medicinal ingredients appeared in authoritative texts. Primary therapeutic or prophylactic use distinguished a medicament from a care product whose medicinal value was merely subsidiary. Small quantities of active ingredients and sale without prescription did not by themselves defeat medicament status. (¶¶ 18.1, 21-26)
- The licensed preparation contained four recognised homeopathic ingredients. Its label, indications and use supported pharmaceutical rather than merely cosmetic character. The absence of stated contraindications or quantified dosage did not displace that conclusion in light of the product’s nature and manner of application. (¶ 22-22.4)
- The words Hair Oil could not be isolated from Homeo and Arnica. Oil served as the application medium for the medicines; the preparation had predominant pharmaceutical value. Nor did the picture of a woman with long hair or general-store availability turn it into a cosmetic. The drug licence was relevant, although not independently conclusive. (¶ 23-28)
- The 2012 rewording and subdivision of the tariff did not materially alter the product’s character or justify reopening its accepted classification. Packaging for retail sale did not move it to Chapter 33: Chapter 30 heading 3004 accommodated medicaments in that form, including homeopathic subheading 3004 90 14. (¶ 30-34)
- The Tribunal correctly set aside the contrary demand, interest and penalty. The Court’s determination concerned this product and the applicable excise entries; it did not treat every oil containing medicinal ingredients as necessarily a medicament. (¶¶ 1.1, 1.2, 21, 34, 35)
Result
Revenue’s appeal dismissed without costs; Tribunal’s medicament classification under Chapter 30 and reversal of the adjudicated demand sustained.